Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
5.33
-0.37 (-6.49%)
At close: Apr 28, 2026, 4:00 PM EDT
5.25
-0.08 (-1.50%)
After-hours: Apr 28, 2026, 5:25 PM EDT
Cadrenal Therapeutics Market Cap
Cadrenal Therapeutics has a market cap or net worth of $16.41 million as of April 28, 2026. Its market cap has decreased by -41.81% in one year.
Market Cap
16.41M
Enterprise Value
13.03M
1-Year Change
-41.81%
Ranking
Category
Stock Price
$5.33
Market Cap Chart
Since the IPO on January 20, 2023, Cadrenal Therapeutics's market cap has decreased from $58.17M to $16.41M, a decrease of -71.80%. That is a compound annual growth rate of -32.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 16.39M | 3.40% |
| Dec 31, 2025 | 15.85M | -38.62% |
| Dec 31, 2024 | 25.83M | 168.05% |
| Dec 29, 2023 | 9.64M | -83.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Passage Bio | 18.73M |
| Psyence Biomedical | 18.14M |
| Lipocine | 17.67M |
| Theriva Biologics | 17.49M |
| Citius Pharmaceuticals | 17.23M |
| Pasithea Therapeutics | 17.21M |
| Genenta Science | 16.71M |
| SeaStar Medical Holding | 16.49M |